106 related articles for article (PubMed ID: 17109659)
1. Exenatide and pramlintide: new therapies for diabetes.
Want LL; Ratner R
Int J Clin Pract; 2006 Dec; 60(12):1522-3. PubMed ID: 17109659
[No Abstract] [Full Text] [Related]
2. Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus.
Hoogwerf BJ
Cleve Clin J Med; 2006 May; 73(5):477-84. PubMed ID: 16708716
[TBL] [Abstract][Full Text] [Related]
3. Diabetes basics. Exenatide and pramlintide. New meds on the block.
Griffin S; Borders J
Diabetes Self Manag; 2006; 23(4):74-6, 79. PubMed ID: 16888865
[No Abstract] [Full Text] [Related]
4. First in class. Two new diabetes drugs.
Koredella T
Diabetes Forecast; 2005 Aug; 58(8):35-6. PubMed ID: 16124101
[No Abstract] [Full Text] [Related]
5. Therapies for diabetes: pramlintide and exenatide.
Jones MC
Am Fam Physician; 2007 Jun; 75(12):1831-5. PubMed ID: 17619527
[TBL] [Abstract][Full Text] [Related]
6. Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide.
Odegard PS; Setter SM; Iltz JL
Diabetes Educ; 2006; 32(5):693-712. PubMed ID: 16971704
[TBL] [Abstract][Full Text] [Related]
7. New drugs: exenatide, pramlintide acetate, and micafungin sodium.
Hussar DA
J Am Pharm Assoc (2003); 2005; 45(4):524-7. PubMed ID: 16128511
[No Abstract] [Full Text] [Related]
8. New therapies for diabetes.
Green DE
Clin Cornerstone; 2007; 8(2):58-63; discussion 64-5. PubMed ID: 18357956
[TBL] [Abstract][Full Text] [Related]
9. Are you up-to-date on diabetes medications?
Scemons D
Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes drug boom: is newer better?
Johns Hopkins Med Lett Health After 50; 2007 Aug; 19(6):3, 7. PubMed ID: 17712909
[No Abstract] [Full Text] [Related]
11. A look back at the most influential drug approvals of 2005.
Laustsen G; Gilbert M; Wimett L
Nurse Pract; 2006 Feb; 31(2):26, 29-36, 41; quiz 42-3. PubMed ID: 16452899
[No Abstract] [Full Text] [Related]
12. New diabetes drugs target gut hormones.
Kuehn BM
JAMA; 2006 Jul; 296(4):380-1. PubMed ID: 16868285
[No Abstract] [Full Text] [Related]
13. Pramlintide: FDA wants more.
Diabetes Obes Metab; 2001 Oct; 3(5):386. PubMed ID: 11710342
[No Abstract] [Full Text] [Related]
14. Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin.
Drugs R D; 1999 Aug; 2(2):118-22. PubMed ID: 10820656
[No Abstract] [Full Text] [Related]
15. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
Baron AD; Kim D; Weyer C
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
[TBL] [Abstract][Full Text] [Related]
16. Is pramlintide an adjunct to insulin therapy?
Charles MA
Diabetes Technol Ther; 2002; 4(2):190-2. PubMed ID: 12079622
[No Abstract] [Full Text] [Related]
17. [Exenatide--an incretin mimetic for treatment of diabetes mellitus type 2].
Musch A; Heinzl S
Med Monatsschr Pharm; 2006 Mar; 29(3):86-9. PubMed ID: 16550880
[No Abstract] [Full Text] [Related]
18. Diabetes: assessing the pipeline.
Lebovitz H
Atheroscler Suppl; 2006 Apr; 7(1):43-9. PubMed ID: 16504599
[TBL] [Abstract][Full Text] [Related]
19. Use of exenatide for weight loss in patients with diabetes.
Virji A
Am Fam Physician; 2007 May; 75(9):1304. PubMed ID: 17511061
[No Abstract] [Full Text] [Related]
20. Type 2 diabetes: the many facets of care.
Hall MA
Home Healthc Nurse; 2008 Jun; 26(6):346-53; quiz 354-5. PubMed ID: 18562819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
